Total Payments
$7,417
2024 Payments
$1,585
Companies
40
Transactions
456
Medicare Patients
8,087
Medicare Billing
$917,391
Payment Breakdown by Category
Food & Beverage$7,417 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,417 | 456 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,717 | 80 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,688 | 147 | $0 (2024) |
| Mylan Specialty L.P. | $391.99 | 27 | $0 (2024) |
| Inari Medical, Inc. | $365.85 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $307.63 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $304.79 | 22 | $0 (2024) |
| Philips Electronics North America Corporation | $281.22 | 18 | $0 (2023) |
| GENZYME CORPORATION | $251.07 | 16 | $0 (2024) |
| United Therapeutics Corporation | $242.55 | 10 | $0 (2023) |
| Genentech USA, Inc. | $223.92 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,585 | 83 | GlaxoSmithKline, LLC. ($483.68) |
| 2023 | $1,249 | 72 | AstraZeneca Pharmaceuticals LP ($285.51) |
| 2022 | $1,177 | 66 | AstraZeneca Pharmaceuticals LP ($299.40) |
| 2021 | $872.16 | 57 | GlaxoSmithKline, LLC. ($163.11) |
| 2020 | $595.71 | 49 | AstraZeneca Pharmaceuticals LP ($152.84) |
| 2019 | $744.43 | 51 | United Therapeutics Corporation ($168.05) |
| 2018 | $545.74 | 41 | GlaxoSmithKline, LLC. ($179.69) |
| 2017 | $647.84 | 37 | AstraZeneca Pharmaceuticals LP ($191.06) |
All Payment Transactions
456 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,221 | 3,010 | $685,754 | $232,568 |
| 2022 | 19 | 1,911 | 2,615 | $597,158 | $205,613 |
| 2021 | 21 | 1,959 | 2,803 | $654,902 | $227,906 |
| 2020 | 21 | 1,996 | 3,088 | $457,547 | $251,304 |
Total Patients
8,087
Total Services
11,516
Medicare Billing
$917,391
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 132 | 282 | $168,072 | $51,096 | 30.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 285 | 613 | $99,669 | $40,749 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 312 | $88,608 | $31,809 | 35.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 171 | 312 | $75,576 | $31,563 | 41.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 168 | 171 | $73,530 | $24,946 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 124 | $24,800 | $8,338 | 33.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 159 | 163 | $30,155 | $8,019 | 26.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 157 | 161 | $23,345 | $6,185 | 26.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 52 | $15,132 | $5,771 | 38.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $14,007 | $5,477 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $13,140 | $4,906 | 37.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 108 | 109 | $21,800 | $3,699 | 17.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $5,530 | $1,817 | 32.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 64 | 67 | $8,040 | $1,608 | 20.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 54 | 54 | $5,940 | $1,556 | 26.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 160 | 161 | $6,440 | $1,549 | 24.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 161 | 162 | $4,698 | $1,159 | 24.7% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 122 | 123 | $3,321 | $822.29 | 24.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,540 | $791.23 | 51.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $605.00 | $361.57 | 59.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 43 | 43 | $1,806 | $345.20 | 19.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 105 | 212 | $126,352 | $38,602 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 313 | $88,892 | $32,232 | 36.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 205 | 364 | $80,444 | $31,720 | 39.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 246 | 480 | $74,400 | $28,825 | 38.7% |
About Dr. Ira Horowitz, M.D
Dr. Ira Horowitz, M.D is a Pulmonary Disease healthcare provider based in Cherry Hill, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780682278.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ira Horowitz, M.D has received a total of $7,417 in payments from pharmaceutical and medical device companies, with $1,585 received in 2024. These payments were reported across 456 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,417).
As a Medicare-enrolled provider, Horowitz has provided services to 8,087 Medicare beneficiaries, totaling 11,516 services with total Medicare billing of $917,391. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Cherry Hill, NJ
- Active Since 07/08/2005
- Last Updated 09/26/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1780682278
Products in Payments
- NUCALA (Biological) $619.51
- TRELEGY ELLIPTA (Drug) $609.72
- DUPIXENT (Biological) $532.76
- FASENRA (Biological) $518.93
- TEZSPIRE (Biological) $403.73
- FLOWTRIEVER CATHETER, S (Device) $365.85
- BREZTRI (Drug) $317.63
- (8874) inCourage (Device) $248.17
- SYMBICORT (Drug) $246.33
- Yupelri (Drug) $224.43
- Xolair (Biological) $180.47
- ORENITRAM (Drug) $175.96
- SMARTVEST (Device) $169.92
- BEVESPI AEROSPHERE (Drug) $165.57
- STIOLTO RESPIMAT (Drug) $152.73
- Arikayce (Drug) $140.30
- FASENRA (Drug) $129.59
- ANORO (Drug) $125.79
- AREXVY (Drug) $125.00
- YUPELRI (Drug) $118.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Cherry Hill
Dr. Steven Baumgarten, M.d, M.D
Pulmonary Disease — Payments: $9,230
Pulmonary Disease $9,230
Dr. Nicholas Roy, D.o, D.O
Pulmonary Disease — Payments: $5,534
Pulmonary Disease $5,534
Dr. David Baumgarten, Md, MD
Pulmonary Disease — Payments: $4,680
Pulmonary Disease $4,680
Steffi Lena, D.o, D.O
Pulmonary Disease — Payments: $1,829
Pulmonary Disease $1,829
Dr. Alan Pope, M.d, M.D
Pulmonary Disease — Payments: $1,164
Pulmonary Disease $1,164
Dipakkumar Malli, Md, MD
Pulmonary Disease — Payments: $134.02
Pulmonary Disease $134.02